Navigation Links
DRAXIMAGE(R)'s generic Sestamibi Approved for launch in USA
Date:5/4/2009

and rest of the world.

GE Healthcare is regarded as a strong player in the nuclear medicine market. It has a very strong network of nuclear pharmacies across the US with a considerable market share in the MPI segment.

DRAXIMAGE(R) Sestamibi is the only generic Tc-99m for MPI, to be marketed by GE, thus complementing GE's product and service offerings to their customers. The initial term of the distribution agreement is for a minimum of three years post approvals and the product is expected to be launched shortly.

About Jubilant Organosys

Jubilant Organosys Ltd. is an integrated pharmaceutical industry player, one of the largest custom research and manufacturing services (CRAMS) and drug discovery and development services companies out of India. The company has a presence across the pharmaceutical value chain for products and services such as proprietary products ,exclusive synthesis, active pharmaceutical ingredients, contract manufacturing of sterile injectables (liquids and lyophilized) products, non-steriles (ointments, creams and liquid) and radiopharmaceuticals, drug discovery services, medicinal chemistry services, clinical research services, generic dosage forms and healthcare. Jubilant Organosys has geographically diversified manufacturing facilities at ten locations worldwide. Together, these help Jubilant cater to 150 customers across more than 50 countries around the world.

For more information: visit www.jubl.com

About Draximage

DRAXIMAGE, develops, manufactures and markets diagnostic and therapeutic radiopharmaceuticals for the global nuclear medicine marketplace.

Products include a proprietary line of lyophilized technetium-99m kits (MAA, MDP, DTPA and Sestamibi) used in several medical imaging procedures. DRAXIMAGE is also a leading supplier of I-131 radiopharmaceuticals in North America, used for the dia
'/>"/>

SOURCE DRAXIS Specialty Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
6. Generic prostate drug helps find high-risk cancers early
7. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
8. Mylan Vice Chairman and CEO Robert J. Coury to Ring NYSE Closing Bell(R) in Celebration of Merck Generics Acquisition
9. FDA Announces Initiative to Bolster Generic Drug Program
10. FDA Struggles to Keep Pace With Requests for Generics
11. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... A new study identifies a molecule that is a ... the molecule could be an important target for colorectal ... , The study of microRNA-135b (miR-135b) in two animal ... Cancer Cell and was led by researchers ... Arthur G. James Cancer Hospital and Richard J. Solove ...
(Date:4/14/2014)... 14In dense, urban centers around the world, many people ... by tall buildings that block sunlight. And as the ... closer together, the darkness will only spread. , ... corrugated, translucent panel that redirects sunlight onto narrow streets ... hung over the edge at an angle, where it ...
(Date:4/14/2014)... Using antibiotics alone to treat children with uncomplicated acute ... to less pain and fewer missed school days, according ... team at Nationwide Children,s Hospital and published online April ... of Surgeons , is the first prospective study on ... the United States. , Researchers enrolled 77 patients ...
(Date:4/14/2014)... it comes to the cost and quality of hospital ... best care when they are treated in units that ... their current job, according to a study from researchers ... School. The study was published in the current issue ... , The review of more than 900,000 patient ...
(Date:4/11/2014)... insights into the processes that control brain cell production ... and other brain-related disorders. , Scientists have gained new ... that controls how and when nerve and brain cells ... to develop and keeps it healthy. Their findings could ... of control, which is a fundamental characteristic of many ...
Breaking Medicine News(10 mins):Health News:Study identifies a likely key driver of colorectal cancer development and progression 2Health News:Let the sun shine in: Redirecting sunlight to urban alleyways 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2
... ... ... ... ...
... ... CyberKnife patients in February 2010, , ... Chicago (PRWEB) February 22, 2010 -- Accelitech LLC ... New Brunswick, NJ, a hospital-based facility operated by Saint Peter’s University Hospital. The ...
... ... ... , ... AAPA honors U.S. Surgeon General Regina Benjamin for commitment to patient care , ...
... ... of the RDX storage technology include industry leaders Dell, Fujitsu, Hitachi, HP, IBM, Imation, Maxell, ... ... announced that Maxell , a technology and marketing leader in premium data storage media ...
... ... proudly offer lead commission on submitted and completed applications as well as multiple tiers of ... advertising partner today and start earning some of the highest affiliate commissions in the financial ... Orem, UT ...
... ... create an opportunity for millions of PowerPoint and Keynote users to up their game ... Santa Clara, ... Ed Kaim unveiled SpeakFlow™, a suite of tools for creating, managing, and delivering non-linear ...
Cached Medicine News:Health News:AppDynamics Announces General Availability of AppDynamics v2.0 2Health News:AppDynamics Announces General Availability of AppDynamics v2.0 3Health News:AppDynamics Announces General Availability of AppDynamics v2.0 4Health News:AppDynamics Announces General Availability of AppDynamics v2.0 5Health News:AppDynamics Announces General Availability of AppDynamics v2.0 6Health News:AppDynamics Announces General Availability of AppDynamics v2.0 7Health News:AppDynamics Announces General Availability of AppDynamics v2.0 8Health News:AppDynamics Announces General Availability of AppDynamics v2.0 9Health News:Accelitech's 2nd New Jersey CyberKnife Site Commences Operations 2Health News:Physician Assistants Call on Congress for Policies That Promote High-Quality Patient Care 2Health News:Physician Assistants Call on Congress for Policies That Promote High-Quality Patient Care 3Health News:Maxell Joins RDX Storage Alliance to Support Growing Storage Professionals' Community 2Health News:Maxell Joins RDX Storage Alliance to Support Growing Storage Professionals' Community 3Health News:Check City Announces New Payday Affiliate Campaign Through Partnership With The Share A Sale Affiliate Network 2Health News:Check City Announces New Payday Affiliate Campaign Through Partnership With The Share A Sale Affiliate Network 3Health News:SharpLogic Announces Launch Of SpeakFlow Non-Linear Presentation Suite At SpeakFlow.com 2Health News:SharpLogic Announces Launch Of SpeakFlow Non-Linear Presentation Suite At SpeakFlow.com 3
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation ... to support older adults suffering from the severe ... AARP and its members are committed to helping those ... AARP and AARP Foundation will match dollar-for-dollar contributions up ... aid. The matching program will be administered through AARP ...
(Date:1/15/2014)... LAWRENCEVILLE, N.J. , Jan. 15, 2014  Celsion ... today announced that it has received commitments from ... $15 million of the Company,s common stock in ... dedicated health care fund. The Company ... pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... 15, 2014 Shire plc (LSE: SHP, ... the Office of Fair Trading (OFT) approval condition to the ... ViroPharma Incorporated (NASDAQ: VPHM).   As a result ... OFT approval, and Shire expects to complete the tender offer ... subject to the satisfaction of all of the remaining conditions ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... 2011 PDI, Inc. (Nasdaq: PDII ), a ... companies, today announced the extension of a contract sales engagement ... began April 1 and will run for the balance of ... PDI of approximately $23 million. Under the program, ...
... April 4, 2011 VIVUS, Inc. (Nasdaq: VVUS ... the investigational drug QNEXA® for two years showed reductions in ... as improvements in lipid levels following significant reductions in weight ... two years. The data – additional results ...
Cached Medicine Technology:PDI Announces Contract Extension With Revenue Value of Approximately $23 Million 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 3
... insulin pen with a memory. HumaPen MEMOIR records the ... (including priming doses). You can see exactly when and ... you simply "dial" your dose by turning the dose ... initial set-up. If you dial too many units, you ...
Assay development using client's antibodies and antigens to meet diagnostic target...
Colloidal Gold Conjugated, Streptavidin - 50 OD...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD...
Medicine Products: